CFO
QGEN icon

Callan Family Office’s Qiagen QGEN Stock Holding History

Callan Family Office’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Buy
8,990
+1,495
+20% +$55.5K 0.01% 939
2026
Q1 		$300K Sell
7,495
-4,605
-38% -$218K 0.01% 932
2025
Q4 		$544K Buy
12,100
+4,037
+50% +$187K 0.01% 757
2025
Q3 		$360K Buy
8,063
+1,741
+28% +$83.3K 0.01% 643
2025
Q2 		$304K Buy
+6,322
New +$275K 0.01% 768

Other funds holding QGEN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Callan Family Office's QGEN Position: Q2 2026 in Review

Callan Family Office increased its Qiagen (QGEN) stake by 20% in Q2 2026, buying an estimated $55.5K and bringing the position to 8,990 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #939.

Callan Family Office first reported a position in QGEN in Q2 2025 and has held it in 5 quarters since. The position peaked at $544K in Q4 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Callan Family Office held 8,990 shares of Qiagen worth $352K as of Q2 2026.
  • Callan Family Office bought 1,495 Qiagen shares in Q2 2026, an estimated $55.5K.
  • Qiagen made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #939 holding.
  • Callan Family Office first reported a position in Qiagen in Q2 2025 and has held it in 5 quarters since.
  • Callan Family Office's Qiagen position peaked at $544K in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.